Validation of a Dutch version of the Neurological Fatigue Index (NFI-MS) for patients with multiple sclerosis in the Netherlands

Quality of Life Research

Volumn 22, Issue 9, 2013, Pages 2435-2441

  Derksen, Arthur ^a   Mokkink, Lidwine B ^a   Rietberg, Marc B ^a   Knol, Dirk L ^a   Ostelo, Raymond W J G ^a,b   Uitdehaag, Bernard M J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Fatigue; Multiple sclerosis; Neurological Fatigue Index for multiple sclerosis (NFI MS); Psychometrics; Reliability; Standard error of measurement; Translation; Validity

Indexed keywords

ADULT; AGED; ARTICLE; CLASSIFICATION; EQUIPMENT; FATIGUE; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NETHERLANDS; PATHOPHYSIOLOGY; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; VALIDATION STUDY;

ADULT; AGED; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NETHERLANDS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 84892811980     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-013-0375-z     Document Type: Article

References (35)

1. Kos, D., Kerckhofs, E., Nagels, G., D'hooghe, M. B., & Ilsbroukx, S. (2008). Origin of fatigue in multiple sclerosis: Review of the literature. Neurorehabilitation & Neural Repair, 22, 91-100.
2. Krupp, L. B., LaRocca, N. G., Muir-Nash, J., & Streinberg, A. D. (1989). The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology, 46, 1121-1122.
3. Kos, D., Kerckhofs, E., Carrea, I., Verza, R., Ramos, M., & Jansa, J. (2005). Evaluation of the Modified Fatigue Impact Scale in four different European Countries. Multiple Sclerosis, 11, 76-80.
4. Vercoulen, J. H., Hommes, O. R., Swanink, C. M., Jongen, P. J., Fennis, J. F., Galama, J. M., et al. (1996). The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Archives of Neurology, 53, 642-649.
5. Rietberg, M. B., Van Wegen, E. E. H., & Kwakkel, G. (2010). Measuring Fatigue in patients with multiple sclerosis: Reproducibility, responsiveness and concurrent validity of three Dutch selfreport questionnaires. Disability and Rehabilitation, 32, 1870-1876.
6. Mills, R. J., Young, C. A., Pallant, J. F., & Tennant, A. (2010). Development of a patient reported outcome scale for fatigue in multiple sclerosis: The Neurological Fatigue Index (NFI-MS). Health and Quality of Life Outcomes, 12, 8-22.
7. Mills, R. J., & Young, C. A. (2008). A medical definition of fatigue in multiple sclerosis. QJM: An International Journal of Medicine, 101, 49-60.
8. Beaton, D. E., Bombardier, C., Guillemin, F., & Ferraz, M. S. (2000). Guidelines for the process of cross-cultural adaption of self-report measures. Spine, 25, 3186-3191.
9. Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H. P., Kappos, L., et al. (2005). Diagnostic criteria for multiple sclerosis revisions to the "McDonald criteria". Annals of Neurology, 58, 840-846.
10. Mokkink, L. B., Terwee, C. B., Patrick, D. L., Alonso, J., Stratford, P. W., Knol, D. L., et al. (2010). The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes. Journal of Clinical Epidemiology, 63, 737-745.
11. Terwee, C. B., Bot, S. D. M., De Boer, M. R., Van der Windt, D. A. W. M., Knol, D. L., Dekker, J., et al. (2007). Quality criteria were proposed for measurement properties of health status questionnaires. Journal of Clinical Epidemiology, 60, 34-42.
12. McGraw, K. O., & Wong, S. P. (1996). Forming inferences about some intraclass correlation coefficients. Psychological Methods, 1, 30-46.
13. Cappelleri, J. C., & Ting, N. (2003). A modified large-sample approach to approximate interval estimation for a particular intraclass correlation coefficient. Statistics in Medicine, 22, 1861-1877.
14. De Vet, H. C. W., Terwee, C. B., Knol, D. L., & Bouter, L. M. (2006). When to use agreement versus reliability measures. Journal of Clinical Epidemiology, 59, 1033-1039.
15. Bland, J. M., & Altman, D. G. (1986). Statistical methods for assessing agreement between two methods of clinical measurement. Lancet, 1, 307-310.
16. Mills, R., Young, C., Nicholas, R., Pallant, J., & Tennant, A. (2009). Rasch analysis of the Fatigue Severity Scale in multiple sclerosis. Multiple Sclerosis, 15, 81-87.
17. Mills, R. J., Young, C. A., Pallant, J., & Tennant, A. (2010). A Rasch analysis of the Modified Fatigue Impact Scale (MFIS) in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 81, 1049-1051.
18. Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67, 361-370.
19. Bjelland, I., Dahl, A. A., Tangen Haug, T., & Neckelmann, D. (2002). The validity of the Hospital Anxiety and Depression Scale. An updated review. Journal of Psychosomatic Research, 52, 69-77.
20. Pfennings, L. E. M. A., Van der Ploeg, H. M., Cohen, L., & Polman, C. H. (1999). Comparison of responsiveness indices in multiple sclerosis patients. Quality of Life Research, 8, 481-489.
21. Hobart, J., Lamping, D., Fitzpatrick, R., Riazi, A., & Thompson, A. (2001). The Multiple Sclerosis Impact Scale (MSIS-29) - A new patient-based outcome measure. Brain, 124, 962-973.
22. Hoogervorst, E., Zwemmer, J., Jelles, B., Polman, C., & Uitdehaag, B. (2004). Multiple Sclerosis Impact Scale (MSIS-29): Relation to established measures of impairment and disability. Multiple Sclerosis, 10, 569-574.
23. Kurtzke, J. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology, 33, 1444-1452.
24. Bowen, J., Gibbons, L., Gianas, A., & Kraft, G. H. (2001). Selfadministrated Expanded Disability Status Scale with functional system scores correlates well with a physician-administered test. Multiple Sclerosis, 7, 201-206.
25. Mills, J., & Young, C. A. (2010). The relationship between fatigue and other clinical features of multiple sclerosis. Multiple Sclerosis Journal, 0, 1-9.
26. Minden, S. L. (2003). Mood disorders in multiple sclerosis: Diagnosis and treatment. Journal of Clinical Endocrinology and Metabolism, 88, 26-30.
27. Arnett, P. A., Barwick, F. H., & Beeney, J. E. (2008). Depression in Multiple Sclerosis: Review and theoretical proposal. Journal of the International Neuropsychological Society, 14, 691-724.
28. Koch, M., Mostert, J., Heerings, M., Uyttenboogaart, M., & De Keyser, J. (2009). Fatigue, depression and disability accumulation in multiple sclerosis: A cross-sectional study. European Journal of Neurology, 16, 348-352.
29. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington DC: American Psychiatric Association.
30. Hurwitz, B. J. (2009). The diagnosis of multiple sclerosis and the clinical subtypes. Annals of Indian Academy of Neurology, 12, 226-230.
31. SPSS. (2006). Base 15.0 for windows user's guide. Chicago, IL: SPSS Inc.
32. Guyatt, G. H., Norman, G. R., Juniper, E. F., & Griffith, L. E. (2002). A critical look at transition ratings. Journal of Clinical Epidemiology, 55, 900-908.
33. Kamper, S. J., Ostelo, R. W. J. G., Knol, D. L., Maher, C. G., De Vet, H. C. W., Hancock, M. J., et al. (2010). Global Perceived Effect scales provided reliable assessments of health transition in people with musculoskeletal disorders, but ratings are strongly influenced by current status. Journal of Clinical Epidemiology, 63, 760-766.
34. Heesen, C., Nawrath, L., Reich, C., Bauer, N., Schulz, K. H., Gold, S. M., et al. (2006). Fatigue in multiple sclerosis: An example of cytokine mediated sickness behaviour? Journal of Neurology, Neurosurgery and Psychiatry, 77, 34-39.
35. Reise, S. P., & Yu, J. (1990). Parameter recovery in the graded response model using MULTILOG. Journal of Educational Measurement, 27, 133-144.